Provention Bio’s $95.7 Million Common Stock Offering

Lowenstein Sandler represented Provention Bio, Inc. in the offering. Provention Bio, Inc., (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, completed its…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now